Showing results (31-40 of 166) with videos related to
Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 19, 2009
Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOPHeidi Nyman, Mats Jerkeman, Marja-Liisa Karjalainen-Lindsberg, et al.British Journal of Haematology|May 10, 2017
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group studyHenrik Cederleuf, Martin Bjerregård Pedersen, Mats Jerkeman, et al.Systematic Reviews|June 22, 2023
HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysisSelamawit F Mekuria, Sydney Timmermans, Christer Borgfeldt, et al.Pharmaceutical Medicine|January 15, 2020
Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare DatabasesTorbjörn Callréus, Tarec Christoffer El-Galaly, Mats Jerkeman, et al.Journal of Clinical and Experimental Hematopathology : JCEH|December 26, 2023
Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphomaMakka Adam, Yonas Bekuretsion, Amha Gebremedhin, et al.BMC Cancer|December 8, 2020
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on riskLavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, et al.Plos One|March 27, 2015
Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancerSven-Erik Olofsson, Björn Nodin, Alexander Gaber, et al.European Journal of Haematology|July 20, 2007
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphomaJohan Linderoth, Mats Ehinger, Måns Akerman, et al.International Journal of Cancer|November 5, 2025
Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphomaSara Ekberg, Ingrid Glimelius, Alexandra Albertsson-Lindblad, et al.Leukemia & Lymphoma|February 17, 2012
Gene expression profiling indicates that immunohistochemical expression of CD40 is a marker of an inflammatory reaction in the tumor stroma of diffuse large B-cell lymphomaKarin Rydström, Patrick Joost, Mats Ehinger, et al.Pageof 17